GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Jafron Biomedical Co Ltd (SZSE:300529) » Definitions » Margin of Safety % (DCF Dividends Based)

Jafron Biomedical Co (SZSE:300529) Margin of Safety % (DCF Dividends Based) : -47.01% (As of Jun. 09, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Jafron Biomedical Co Margin of Safety % (DCF Dividends Based)?

Margin of Safety % (DCF Dividends Based) = (Intrinsic Value: DCF (Dividends Based) - Current Price) / Intrinsic Value: DCF (Dividends Based).

Note: Discounted Dividend model is only suitable for companies who have a consistant distribution history with more than 5 years. If the company's dividends does not remain steady over a long period, results may not be accurate due to the low consistency. The model is also only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, the data will not be stored into our database.

As of today (2024-06-09), Jafron Biomedical Co's Predictability Rank is 4-Stars. Jafron Biomedical Co's intrinsic value calculated from the Discounted Dividend model is ¥20.50 and current share price is ¥27.49. Consequently,

Jafron Biomedical Co's Margin of Safety % (DCF Dividends Based) using Discounted Dividend model is -47.01%.

Competitive Comparison of Jafron Biomedical Co's Margin of Safety % (DCF Dividends Based)

For the Medical Devices subindustry, Jafron Biomedical Co's Margin of Safety % (DCF Dividends Based), along with its competitors' market caps and Margin of Safety % (DCF Dividends Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Jafron Biomedical Co's Margin of Safety % (DCF Dividends Based) Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Jafron Biomedical Co's Margin of Safety % (DCF Dividends Based) distribution charts can be found below:

* The bar in red indicates where Jafron Biomedical Co's Margin of Safety % (DCF Dividends Based) falls into.


Jafron Biomedical Co Margin of Safety % (DCF Dividends Based) Calculation

Jafron Biomedical Co's Margin of Safety % (DCF Dividends Based) for today is calculated as

Margin of Safety % (DCF Dividends Based)=(Intrinsic Value: DCF (Dividends Based)-Current Price)/Intrinsic Value: DCF (Dividends Based)
=(18.70-27.49)/18.70
=-47.01 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The intrinsic value is calculated from the Discounted Dividend model with default parameters.

Jafron Biomedical Co Margin of Safety % (DCF Dividends Based) Related Terms

Thank you for viewing the detailed overview of Jafron Biomedical Co's Margin of Safety % (DCF Dividends Based) provided by GuruFocus.com. Please click on the following links to see related term pages.

Jafron Biomedical Co (SZSE:300529) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Jafron Biomedical Co Ltd (SZSE:300529) » Definitions » Margin of Safety % (DCF Dividends Based)
Comparable Companies
SHSE:688198 SZSE:300633 SZSE:300298 SHSE:688161 SZSE:002901 SHSE:688617 SZSE:301363 SHSE:688016 SHSE:603658 SHSE:600055 ABT SYK MDT BSX SZSE:300760 EW DXCM ZBH STE XAMS:PHIA
Traded in Other Exchanges
N/A
Address
No. 98, Science and Technology 6th Road, High-tech Zone, Guangdong Province, Zhuhai, CHN, 519085
Website
http://www.jafron.com
Jafron Biomedical Co Ltd is a China-based company engaged in the research, development, production, and sales of biomaterials and medical devices. It offers solutions for kidney disease, poisoning, rheumatic immune solution, critical illness and liver disease. The company's products include JFYC-100 pre-punching machine, DX-10 blood purifier, and HA resin hemoperfusion.
Executives
Li Feng Director
He Xiao Lian Executives
Dong Fan Directors, Directors, and Executives
Ceng Kai Directors, executives
Tang Xian Min Directors, executives
Zhang Ming Yuan Secretary Dong
Fang Li Hua Supervisors
Zhang Guang Hai Directors, executives
Li De Zhi Executives
Lu Shao Zhang Executives

Jafron Biomedical Co (SZSE:300529) Headlines

No Headlines